MLL-AF4与PAF1和FACT合作,在白血病中驱动高密度增强剂相互作用
Nicholas T Crump1,2, Alastair L Smith3, Laura Godfrey3
1MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK. n.crump@imperial.ac.uk.
Nature communications
|August 25, 2023
概括
异常的增强器激活驱动癌症. 这项研究表明,MLL-AF4融合蛋白在白血病中产生广泛的增强剂-促进剂相互作用,这取决于像PAF1C和FACT这样的转录延长因子.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 遗传学 是一个遗传学.
背景情况:
- 异常增强剂激活驱动癌症中的癌基因表达.
- 增强剂-促进剂相互作用对于基因调节至关重要,但人们对其了解甚少.
- 讨论了BRD4和Mediator等联合激活剂在这些相互作用中的作用.
研究的目的:
- 研究MLL-AF4融合蛋白在白血病中增强剂-促进剂相互作用中的作用.
- 阐明了MLL-AF4驱动的瘤基因表达背后的分子机制.
- 探索转录延长因子在增强剂-促进剂交叉声响中的参与.
主要方法:
- 使用微捕获-C (MCC),一种超高分辨率技术.
- 在MLL-AF4驱动的白血病中分析了增强剂-促进剂相互作用.
- 评估了转录延长因子 (PAF1C,FACT) 对这些相互作用的影响.
主要成果:
- 在特定的目标基因中,MLL-AF4结合促进了广泛的,高密度的增强剂-促进剂相互作用.
- 这些向增强剂被丰富为转录延长因子.
- 耗尽PAF1C或FACT消除了增强剂-促进剂接触.
结论:
- 在白血病中,MLL-AF4通过广泛的增强剂-促进剂相互作用驱动高基因转录.
- 转录延长因子对于维持这些相互作用至关重要.
- 这表明一种通用模型将增强剂-促进剂交叉声和癌症中转录延长联系在一起.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K


